SNAP25 and early-onset autosomal dominant Alzheimer disease: Moreover, CSF SNAP-25 levels, determined using mass spectrometry, were significantly elevated in early-stage and established Alzheimer’s disease, and the biomarker was able to meaningfully discriminate patients with the disease from healthy controls with an area under the curve of 0.901 [311].